Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma (Q43922127)
scientific article published in February 2002
Language:
Current Data About Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma
(P31) (Q13442814)
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

(P50) (Q57840070)

(P304) 169-172
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

(P407) (Q1860)
(P887)

(P433) 2
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

(P478) 13
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

(P577) Friday, February 1, 2002
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

(P921) (Q42824440)

(Q510113)
(P248)
(P683) 90225

(P1433) (Q4774128)
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

(P1476) "Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma" (language: en)
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

(P2093) Julie A Ellerhorst
(P1545) 1
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

Agop Y Bedikian
(P1545) 2
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

Teresa M Smith
(P1545) 3
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

Nicholas E Papadopoulos
(P1545) 4
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

Carl Plager
(P1545) 5
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

Omar Eton
(P1545) 6
(P248)
(P698) 11901310
(P813) Tuesday, November 28, 2017

other details
description scientific article published in February 2002

External Links
(P356) 10.1097/00001813-200202000-00009
(P698) 11901310